BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26895716)

  • 1. Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.
    Fujieda Y; Amengual O; Matsumoto M; Kuroki K; Takahashi H; Kono M; Kurita T; Otomo K; Kato M; Oku K; Bohgaki T; Horita T; Yasuda S; Maenaka K; Hatakeyama S; Nakayama KI; Atsumi T
    Rheumatology (Oxford); 2016 Jun; 55(6):1117-26. PubMed ID: 26895716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.
    Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T
    Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of CD36 in monocyte activation by antiphospholipid antibodies.
    Kato M; Atsumi T; Oku K; Amengual O; Nakagawa H; Fujieda Y; Otomo K; Horita T; Yasuda S; Koike T
    Lupus; 2013 Jul; 22(8):761-71. PubMed ID: 23817509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
    López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
    Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified phosphatidylserine-dependent antiprothrombin [corrected] ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies.
    Žigon P; Ambrožič A; Čučnik S; Kveder T; Rozman B; Božič B
    Clin Chem Lab Med; 2011 Jun; 49(6):1011-8. PubMed ID: 21574879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
    Yasuda S; Bohgaki M; Atsumi T; Koike T
    Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiprothrombin antibody: why do we need more assays?
    Atsumi T; Koike T
    Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiprothrombin antibody testing: detection and clinical utility.
    Oku K; Atsumi T; Amengual O; Koike T
    Semin Thromb Hemost; 2008 Jun; 34(4):335-9. PubMed ID: 18814066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
    Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
    Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. aCL/β
    Kaneshige R; Nojima J; Motoki Y; Tsuneoka H
    Thromb Res; 2019 Sep; 181():52-58. PubMed ID: 31351266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patients.
    Sciascia S; Sanna G; Murru V; Khamashta MA; Bertolaccini ML
    Thromb Res; 2014 Mar; 133(3):451-4. PubMed ID: 24342537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New tests to detect antiphospholipid antibodies: antiprothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies.
    Sciascia S; Khamashta MA; Bertolaccini ML
    Curr Rheumatol Rep; 2014 May; 16(5):415. PubMed ID: 24609824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
    Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
    Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?
    Žigon P; Čučnik S; Ambrožič A; Sodin Šemrl S; Kveder T; Božič B
    Lupus; 2012 Jun; 21(7):790-2. PubMed ID: 22635235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
    Bohgaki M; Atsumi T; Yamashita Y; Yasuda S; Sakai Y; Furusaki A; Bohgaki T; Amengual O; Amasaki Y; Koike T
    Int Immunol; 2004 Nov; 16(11):1633-41. PubMed ID: 15466912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells.
    Vega-Ostertag M; Liu X; Kwan-Ki H; Chen P; Pierangeli S
    Br J Haematol; 2006 Oct; 135(2):214-9. PubMed ID: 16965389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.